Hu W, Sancho-Serra C, Gantner CW, Szafranska HM, Solanky N, Metcalfe K, Vento-Tormo & Zernicka-Goetz. Atlas of amnion development during the first trimester of human pregnancy. Nature Cell Biology (2025)
Gantner CW*, Weatherbee BAT*, Wang Y & Zernicka-Goetz M. Assembly of a stem cell-derived human post-implantation embryo model. *Equal contribution. Nature Protocols (2025)
Weatherbee BAT*, Weberling A*, Gantner CW*, Iwamoto-Stohl L, Barnikel Z, Campbell A, Fisher S, Chowdhury N, Richardson L, Mania A, Weavers L, Christie L, Elder K, Snell P & Zernicka-Goetz M. Distinct pathways drive anterior hypoblast specification in the implanting human embryo. *Equal contribution. Nature Cell Biology (2024)
Weatherbee BAT*, Gantner CW*, Iwamoto-Stohl L, Daza RM, Hamazaki N, Shendure J & Zernicka-Goetz M. A model of the post-implantation human embryo derived from pluripotent stem cells. *Equal contribution. Nature (2023)
Lau KYC*, Rubinstein H*, Gantner CW, Hadas R, Amadei G, Stelzer Y & Zernicka-Goetz. Mouse embryo model derived exclusively from embryonic stem cells undergoes neurulation and heart development. *Equal contribution. Cell Stem Cell (2022).
Moriarty N, Gantner CW, Hunt CPJ, Ermine CM, Frausin S, Viventi S, Ovchinnikov DA, Kirik D, Parish CL & Thompson LH. A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells. Cell Stem Cell (2022)
Gantner CW*, Hunt CPJ*, Niclis JC, Penna V, McDougall SJ, Thompson LH & Parish CL. FGF-MAPK signaling regulates human deep-layer corticogenesis. *Equal contribution. Stem Cell Reports (2021)
Gantner CW*, Cota-Coronado A*, Thompson LH & Parish CL. An Optimized Protocol for the Generation of Midbrain Dopamine Neurons under Defined Conditions. *Equal contribution. STAR Protocols (2020)
Gantner CW, de Luzy IR, Kauhausen JA, Moriarty N, Niclis JC, Bye CR, Penna V, Hunt CPJ, Ermine CM, Pouton CW, Kirik D, Thompson LH & Parish CL. Viral Delivery of GDNF Promotes Functional Integration of Human Stem Cell Grafts in Parkinson's Disease. Cell Stem Cell (2020)
Niclis JC*, Gantner CW*, Alsanie WF, McDougall SJ, Bye CR, Elefanty AG, Stanley EG, Haynes JM, Pouton CW, Thompson LH & Parish CL. Efficiently specified ventral midbrain dopamine neurons from human pluripotent stem cells under xeno-free conditions restore motor deficits in Parkinsonian rodents. *Equal contribution. Stem Cells Translational Medicine (2017)
Selected publications
For a full list please see Carlos' ORCiD
